Precipio, Inc.
PRPOHealthcareNASDAQDiagnostics & Research · Last scanned Jul 22, 2026
Scan Results
Daily timeframeHeadquartered within the healthcare sector, Precipio, Inc. focuses on Diagnostics & Research services and products. Precipio, Inc., a healthcare biotechnology company, provides cancer diagnostic products, reagents, and services in the United States. With a market capitalization of $42.4M, it sits in micro-cap territory. It provides diagnostic blood cancer testing services.
Market Cap
$42.4M
Beta
1.28
P/E (TTM)
—
P/E (Fwd)
60.77
EPS (TTM)
$-0.45
EPS (Fwd)
$0.39
ROE
-7.1%
ROA
-5.7%
Cash
$2.6M
Total Debt
$3.5M
Free CF
$642,750
52W Change
71.7%
Annual Financials
Cash vs Debt
Where PRPO stands vs its 150-day and 200-day moving averages
As of the July 14, 2026 close, PRPO finished 4.76% below its 150-day moving average ($25.20) and 0.25% below its 200-day moving average ($24.06). This snapshot is end-of-day data shown with a five-trading-day delay on the free plan; Premium members see readings from the latest close.
Is PRPO overbought or oversold?
At the July 14, 2026 close, PRPO's RSI(14) was 54.8, in neutral territory (between 30 and 70). The MACD histogram was positive, so short-term momentum leaned bullish at that close. These readings are historical, refresh daily after market close, and are not investment advice.
The company holds $2.6M in cash, though total debt stands at $3.5M. This level of leverage is common in the industry but worth monitoring as interest rate conditions evolve. Annual free cash flow of $643K supports ongoing capital allocation decisions and provides a cushion against unexpected expenses or downturns. ROE of -7.1% points to negative capital efficiency, indicating how much profit the company produces per dollar of shareholder equity. Revenue has grown from $9.4M (2022) to $24.0M (2025), reflecting a 156% increase over the period.
Investors considering Precipio, Inc. should weigh the typical risks associated with PRPO's sector, size, and financial profile against their own risk tolerance and investment objectives. It is important to consider these factors alongside broader market conditions and individual financial goals when reviewing PRPO.